Public Companies

Apr. 16, 2026

Modular Medical Regains Nasdaq Compliance

Insulin delivery company meets minimum bid price requirement after recent stock price drop.

Apr. 16, 2026

QuidelOrtho Announces Preliminary Q1 2026 Revenue, Updates Full-Year Guidance

Macroeconomic challenges and softer respiratory season impact first quarter, but company remains focused on operational execution and long-term growth.

Apr. 16, 2026

Concorde International Group Investors Urged to Contact Robbins LLP About Potential Losses

Law firm investigates allegations of a pump-and-dump scheme involving the security services company's stock.

Apr. 16, 2026

Modular Medical Regains Nasdaq Compliance

Insulin delivery company meets minimum bid price requirement after recent dip.

Apr. 16, 2026

WD-40 Sees Stronger Q2 Sales, Reaffirms Full-Year Guidance

Maintenance product sales drive growth, but higher costs could impact profitability in H2

Apr. 16, 2026

Robbins LLP Encourages Pinterest Investors to Join Class Action

Law firm seeks lead plaintiff for lawsuit against Pinterest over alleged revenue misrepresentation

Apr. 16, 2026

Investors Seek Compensation After Gemini Space Station IPO Losses

Robbins LLP Investigating Allegations of Misleading Statements in Gemini's Offering Documents

Apr. 16, 2026

Inseego Corp. to Report Q1 2026 Earnings on May 7

The 5G technology company will host a conference call to discuss its financial results and business outlook.

Apr. 16, 2026

Inseego Corp. to Report First Quarter 2026 Financial Results

The 5G mobile broadband and fixed wireless access solutions provider will release earnings on May 7, 2026.

Apr. 16, 2026

Robbins LLP Urges ImmunityBio Shareholders to Join Class Action

Law firm investigates allegations that biotech firm misled investors about lead drug candidate

Apr. 16, 2026

Robbins LLP Investigating Aldeyra Therapeutics for Misleading Investors

Law firm encourages shareholders who lost money to contact them about leading class action lawsuit.

Apr. 16, 2026

Robbins LLP Encourages Pinterest Shareholders to Join Class Action Lawsuit

Law firm seeks lead plaintiff for case alleging Pinterest misled investors about advertising revenue impacts.

Apr. 16, 2026

Robbins LLP Encourages GOSS Stockholders to Join Class Action Against Gossamer Bio

Law firm seeks lead plaintiff for lawsuit alleging Gossamer Bio misled investors about its PROSERA drug trial.

Apr. 16, 2026

Robbins LLP Encourages Gossamer Bio Investors to Join Class Action

Law firm investigating allegations that Gossamer misled investors about its PROSERA study

Apr. 16, 2026

Atara Biotherapeutics Investors Urged to Recover Losses

Robbins LLP Investigates Allegations of Misleading Investors About Drug Candidate

Apr. 16, 2026

Investors with Substantial Losses Have Opportunity to Lead monday.com Class Action Lawsuit

The lawsuit alleges monday.com misled investors about its growth and revenue outlook.

Apr. 16, 2026

Crinetics Pharmaceuticals Reports Strong Q4 and Full Year 2025 Results

Approval and Launch of PALSONIFY Drives Robust Revenue Growth

Apr. 16, 2026

Driven Brands Investors Seek Lead Plaintiff in Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP announces opportunity for Driven Brands shareholders to lead lawsuit over accounting errors.

Apr. 16, 2026

XPeng Files 2025 Annual Report on Form 20-F

Chinese EV maker XPeng announces filing of its latest annual report with the SEC.

Apr. 15, 2026

Babcock & Wilcox Investors Seek Lead Plaintiff in Class Action Lawsuit

Lawsuit alleges company misled investors about relationship with largest shareholder and counterparty